Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 30, 2025 Life Science Investing
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis Geography